Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Maculopathies”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05536752
What this trial is testing

QA102 Phase II Study in Subjects With Dry AMD

Who this might be right for
Dry Age-related Macular Degeneration
Smilebiotek Zhuhai Limited 150
Not applicableUnknownNCT03750149
What this trial is testing

Reading Analysis in Ophthalmologic Patients

Who this might be right for
Diabetic MaculopathyAge Related Macular DegenerationGlaucoma+1 more
Prim. Prof. Dr. Oliver Findl, MBA 100
Not applicableStudy completedNCT04522999
What this trial is testing

Study of Photobiomodulation Effect on Electroretinogram Outcomes in Dry Age-Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
LumiThera, Inc. 15
Large-scale testing (Phase 3)Study completedNCT04522167
What this trial is testing

Efficacy and Safety of the Aflibercept FYB203 Biosimilar in Comparison to Eylea® in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Bioeq GmbH 434
Testing effectiveness (Phase 2)Looking for participantsNCT06672536
What this trial is testing

Multicenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMD

Who this might be right for
nAMD
Sinocelltech Ltd. 82
Testing effectiveness (Phase 2)UnknownNCT00684853
What this trial is testing

Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD

Who this might be right for
Macular Degeneration
Federal University of São Paulo 50
Large-scale testing (Phase 3)Looking for participantsNCT07695207
What this trial is testing

Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy
SANGMYUNG innovation 266
Large-scale testing (Phase 3)Study completedNCT04047472
What this trial is testing

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 397
Large-scale testing (Phase 3)Study completedNCT00964795
What this trial is testing

Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Regeneron Pharmaceuticals 323
Not applicableStudy completedNCT04662944
What this trial is testing

A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 494
Testing effectiveness (Phase 2)Ended earlyNCT03869684
What this trial is testing

Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Senju Pharmaceutical Co., Ltd. 13
Early research (Phase 1)UnknownNCT05005884
What this trial is testing

Possible Effects of Supplement Therapy With Oral Phenolics on Cluster of Differentiation 163 (CD-163) Biomarker of Patients With Age-related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Shahid Beheshti University of Medical Sciences 80
Not applicableUnknownNCT01676506
What this trial is testing

Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Russian Academy of Medical Sciences 300
Post-approval studies (Phase 4)Study completedNCT02060604
What this trial is testing

Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Università degli Studi di Brescia 60
Not applicableLooking for participantsNCT07515521
What this trial is testing

Enhanced Vision and Imaging Tests for Enabling Treatment Trials in Early and Intermediate AMD

Who this might be right for
Age - Related Macular Degeneration (AMD)
Maximilian Pfau 150
Not applicableEnded earlyNCT00993330
What this trial is testing

Macular Pigment Optical Density in Healthy Subjects

Who this might be right for
Age Related Macular Degeneration
Medical University of Vienna 96
Testing effectiveness (Phase 2)Study completedNCT05456828
What this trial is testing

ASKG712 in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Visara, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT02713204
What this trial is testing

Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection

Who this might be right for
Neovascular Age-Related Macular Degeneration
Regeneron Pharmaceuticals 365
Post-approval studies (Phase 4)Study completedNCT03022292
What this trial is testing

The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy

Who this might be right for
Wet Macular Degeneration
University of California, Los Angeles 26
Early research (Phase 1)Active Not RecruitingNCT06198413
What this trial is testing

LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration
Innostellar Biotherapeutics Co.,Ltd 12
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation